Cytovance Biologics

Cytovance Biologics is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in the production of therapeutic proteins and antibodies. The company provides a full suite of services ranging from cell line development and process development to clinical and commercial cGMP manufacturing. Their expertise spans mammalian cell culture, microbial fermentation, and plasmid DNA (pDNA) production. Headquartered in Oklahoma City, Cytovance operates an 'Ingenuity Campus' featuring state-of-the-art facilities designed for scalability and regulatory compliance. Since its acquisition by the Hepalink Group, the company has significantly expanded its capacity, including the integration of single-use technologies and advanced fill-finish capabilities through strategic partnerships.